Figure 6
Figure 6. Chronic treatment with RO-82 and RO-68 (20-60 mg/kg daily for 1 week) inhibited liver hepcidin and spleen iron. Mice (8-9 weeks old) were treated with RO-82 and RO-68 (20-60 mg/kg daily for 1 week) and euthanized. Hepcidin (A) and Id1(B) mRNA were quantified by qRT-PCR in relationship to Hprt1 mRNA. Data are representative of 4 mice/point and are expressed with box plot histograms. Hepcidin and Id1 level are expressed as percentage of untreated mice (100%). pSMAD1/5/8 and SMAD1 were evaluated in untreated and treated (60 mg/kg RO-82 and RO-68) mice by western blotting (C). Serum hepcidin was measured by surface enhanced laser desorption ionization–time of flight mass spectrometry (D), and spleen iron was measured spectrophotometrically (E).

Chronic treatment with RO-82 and RO-68 (20-60 mg/kg daily for 1 week) inhibited liver hepcidin and spleen iron. Mice (8-9 weeks old) were treated with RO-82 and RO-68 (20-60 mg/kg daily for 1 week) and euthanized. Hepcidin (A) and Id1(B) mRNA were quantified by qRT-PCR in relationship to Hprt1 mRNA. Data are representative of 4 mice/point and are expressed with box plot histograms. Hepcidin and Id1 level are expressed as percentage of untreated mice (100%). pSMAD1/5/8 and SMAD1 were evaluated in untreated and treated (60 mg/kg RO-82 and RO-68) mice by western blotting (C). Serum hepcidin was measured by surface enhanced laser desorption ionization–time of flight mass spectrometry (D), and spleen iron was measured spectrophotometrically (E).

Close Modal

or Create an Account

Close Modal
Close Modal